Vyant Bio, Inc. Quarterly Debt-to-equity in % from Q3 2013 to Q4 2022

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Vyant Bio, Inc. quarterly Debt-to-equity history and growth rate from Q3 2013 to Q4 2022.
  • Vyant Bio, Inc. Debt-to-equity for the quarter ending December 31, 2022 was 55.1 %, a 357% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q4 2022 55.1 +43.1 +357% Dec 31, 2022
Q3 2022 42.4 +21.1 +98.7% Sep 30, 2022
Q2 2022 25.2 -31.4 -55.4% Jun 30, 2022
Q1 2022 16 +98.7 Mar 31, 2022
Q4 2021 12.1 +35.5 Dec 31, 2021
Q3 2021 21.3 +43.1 Sep 30, 2021
Q2 2021 56.5 +99.6 Jun 30, 2021
Q1 2021 -82.7 +49.8 +37.6% Mar 31, 2021
Q4 2020 -23.4 +1K +97.7% Dec 31, 2020
Q3 2020 -21.8 -412 -106% Sep 30, 2020
Q2 2020 -43.1 -469 -110% Jun 30, 2020
Q1 2020 -132 -411 -148% Mar 31, 2020
Q4 2019 -1.03K -1.23K -599% Dec 31, 2019
Q3 2019 390 +245 +169% Sep 30, 2019
Q2 2019 426 +323 +311% Jun 30, 2019
Q1 2019 278 +178 +177% Mar 31, 2019
Q4 2018 206 +110 +115% Dec 31, 2018
Q3 2018 145 +57.7 +65.8% Sep 30, 2018
Q2 2018 104 +18.2 +21.3% Jun 30, 2018
Q1 2018 100 +30.6 +43.9% Mar 31, 2018
Q4 2017 95.5 +36.4 +61.6% Dec 31, 2017
Q3 2017 87.6 +33.1 +60.5% Sep 30, 2017
Q2 2017 85.5 +32.1 +60% Jun 30, 2017
Q1 2017 69.8 +17.1 +32.3% Mar 31, 2017
Q4 2016 59.1 +10.6 +21.9% Dec 31, 2016
Q3 2016 54.6 +9.66 +21.5% Sep 30, 2016
Q2 2016 53.4 +14 +35.4% Jun 30, 2016
Q1 2016 52.8 +19.8 +59.9% Mar 31, 2016
Q4 2015 48.5 +19.9 +69.7% Dec 31, 2015
Q3 2015 44.9 +19.9 +79.7% Sep 30, 2015
Q2 2015 39.5 +11.4 +40.8% Jun 30, 2015
Q1 2015 33 -15.1 -31.4% Mar 31, 2015
Q4 2014 28.6 -251 -89.8% Dec 31, 2014
Q3 2014 25 +203 Sep 30, 2014
Q2 2014 28 Jun 30, 2014
Q1 2014 48.1 Mar 31, 2014
Q4 2013 280 Dec 31, 2013
Q3 2013 -178 Sep 30, 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.